Incidental Mutation 'IGL02680:Steap2'
ID |
303329 |
Institutional Source |
Australian Phenomics Network
(link to record)
|
Gene Symbol |
Steap2
|
Ensembl Gene |
ENSMUSG00000015653 |
Gene Name |
six transmembrane epithelial antigen of prostate 2 |
Synonyms |
4921538B17Rik |
Accession Numbers |
|
Essential gene? |
Non essential
(E-score: 0.000)
|
Stock # |
IGL02680
|
Quality Score |
|
Status
|
|
Chromosome |
5 |
Chromosomal Location |
5714829-5744578 bp(-) (GRCm39) |
Type of Mutation |
missense |
DNA Base Change (assembly) |
A to T
at 5723474 bp (GRCm39)
|
Zygosity |
Heterozygous |
Amino Acid Change |
Phenylalanine to Isoleucine
at position 469
(F469I)
|
Ref Sequence |
ENSEMBL: ENSMUSP00000132501
(fasta)
|
Gene Model |
predicted gene model for transcript(s):
[ENSMUST00000015797]
[ENSMUST00000115424]
[ENSMUST00000115425]
[ENSMUST00000115426]
[ENSMUST00000115427]
[ENSMUST00000148333]
[ENSMUST00000164219]
|
AlphaFold |
Q8BWB6 |
Predicted Effect |
probably benign
Transcript: ENSMUST00000015797
AA Change: F469I
PolyPhen 2
Score 0.004 (Sensitivity: 0.98; Specificity: 0.59)
|
SMART Domains |
Protein: ENSMUSP00000015797 Gene: ENSMUSG00000015653 AA Change: F469I
Domain | Start | End | E-Value | Type |
Pfam:F420_oxidored
|
31 |
118 |
8.9e-19 |
PFAM |
transmembrane domain
|
209 |
231 |
N/A |
INTRINSIC |
Pfam:Ferric_reduct
|
258 |
405 |
2.8e-16 |
PFAM |
transmembrane domain
|
431 |
453 |
N/A |
INTRINSIC |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000115424
AA Change: F469I
PolyPhen 2
Score 0.004 (Sensitivity: 0.98; Specificity: 0.59)
|
SMART Domains |
Protein: ENSMUSP00000111084 Gene: ENSMUSG00000015653 AA Change: F469I
Domain | Start | End | E-Value | Type |
Pfam:F420_oxidored
|
31 |
118 |
4e-18 |
PFAM |
transmembrane domain
|
209 |
231 |
N/A |
INTRINSIC |
Pfam:Ferric_reduct
|
258 |
406 |
1.5e-22 |
PFAM |
transmembrane domain
|
431 |
453 |
N/A |
INTRINSIC |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000115425
AA Change: F469I
PolyPhen 2
Score 0.004 (Sensitivity: 0.98; Specificity: 0.59)
|
SMART Domains |
Protein: ENSMUSP00000111085 Gene: ENSMUSG00000015653 AA Change: F469I
Domain | Start | End | E-Value | Type |
Pfam:F420_oxidored
|
31 |
118 |
4e-18 |
PFAM |
transmembrane domain
|
209 |
231 |
N/A |
INTRINSIC |
Pfam:Ferric_reduct
|
258 |
406 |
1.5e-22 |
PFAM |
transmembrane domain
|
431 |
453 |
N/A |
INTRINSIC |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000115426
AA Change: F469I
PolyPhen 2
Score 0.004 (Sensitivity: 0.98; Specificity: 0.59)
|
SMART Domains |
Protein: ENSMUSP00000111086 Gene: ENSMUSG00000015653 AA Change: F469I
Domain | Start | End | E-Value | Type |
Pfam:F420_oxidored
|
31 |
118 |
4e-18 |
PFAM |
transmembrane domain
|
209 |
231 |
N/A |
INTRINSIC |
Pfam:Ferric_reduct
|
258 |
406 |
1.5e-22 |
PFAM |
transmembrane domain
|
431 |
453 |
N/A |
INTRINSIC |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000115427
|
SMART Domains |
Protein: ENSMUSP00000111087 Gene: ENSMUSG00000015653
Domain | Start | End | E-Value | Type |
Pfam:F420_oxidored
|
31 |
118 |
2.3e-17 |
PFAM |
transmembrane domain
|
209 |
231 |
N/A |
INTRINSIC |
Pfam:Ferric_reduct
|
258 |
401 |
1.8e-21 |
PFAM |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000148333
|
SMART Domains |
Protein: ENSMUSP00000116910 Gene: ENSMUSG00000015653
Domain | Start | End | E-Value | Type |
Pfam:F420_oxidored
|
31 |
118 |
8.3e-18 |
PFAM |
transmembrane domain
|
209 |
231 |
N/A |
INTRINSIC |
Pfam:Ferric_reduct
|
258 |
406 |
2.7e-22 |
PFAM |
transmembrane domain
|
431 |
453 |
N/A |
INTRINSIC |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000164219
AA Change: F469I
PolyPhen 2
Score 0.004 (Sensitivity: 0.98; Specificity: 0.59)
|
SMART Domains |
Protein: ENSMUSP00000132501 Gene: ENSMUSG00000015653 AA Change: F469I
Domain | Start | End | E-Value | Type |
Pfam:F420_oxidored
|
31 |
118 |
4e-18 |
PFAM |
transmembrane domain
|
209 |
231 |
N/A |
INTRINSIC |
Pfam:Ferric_reduct
|
258 |
406 |
1.5e-22 |
PFAM |
transmembrane domain
|
431 |
453 |
N/A |
INTRINSIC |
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000149412
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000150238
|
Coding Region Coverage |
|
Validation Efficiency |
|
MGI Phenotype |
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene is a member of the STEAP family and encodes a multi-pass membrane protein that localizes to the Golgi complex, the plasma membrane, and the vesicular tubular structures in the cytosol. A highly similar protein in mouse has both ferrireductase and cupric reductase activity, and stimulates the cellular uptake of both iron and copper in vitro. Increased transcriptional expression of the human gene is associated with prostate cancer progression. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
|
Allele List at MGI |
|
Other mutations in this stock |
Total: 35 list
Gene | Ref | Var | Chr/Loc | Mutation | Predicted Effect | Zygosity |
4921524L21Rik |
T |
A |
18: 6,635,949 (GRCm39) |
|
probably benign |
Het |
Aldh1a3 |
C |
A |
7: 66,055,895 (GRCm39) |
V299F |
probably damaging |
Het |
Ankar |
A |
G |
1: 72,709,275 (GRCm39) |
Y747H |
probably damaging |
Het |
Armc9 |
T |
C |
1: 86,180,000 (GRCm39) |
I107T |
probably damaging |
Het |
Atmin |
A |
T |
8: 117,684,236 (GRCm39) |
D632V |
probably damaging |
Het |
Atp5pd |
C |
A |
11: 115,306,840 (GRCm39) |
|
probably null |
Het |
Cadps2 |
T |
C |
6: 23,838,895 (GRCm39) |
E81G |
probably damaging |
Het |
Cep162 |
A |
G |
9: 87,128,797 (GRCm39) |
V67A |
possibly damaging |
Het |
Cfap100 |
C |
T |
6: 90,389,217 (GRCm39) |
V335I |
probably benign |
Het |
Dmtf1 |
A |
T |
5: 9,180,381 (GRCm39) |
D181E |
probably benign |
Het |
Efcab14 |
T |
A |
4: 115,597,615 (GRCm39) |
I70N |
probably damaging |
Het |
Frzb |
T |
C |
2: 80,254,970 (GRCm39) |
T189A |
possibly damaging |
Het |
Fstl3 |
G |
A |
10: 79,614,506 (GRCm39) |
W69* |
probably null |
Het |
Gjb3 |
C |
T |
4: 127,219,815 (GRCm39) |
C239Y |
probably damaging |
Het |
Ifna1 |
A |
G |
4: 88,768,523 (GRCm39) |
D67G |
probably benign |
Het |
Inpp5d |
A |
G |
1: 87,629,205 (GRCm39) |
T397A |
possibly damaging |
Het |
Myh11 |
G |
T |
16: 14,027,384 (GRCm39) |
H1283Q |
probably benign |
Het |
Naip6 |
A |
G |
13: 100,420,256 (GRCm39) |
V1338A |
probably benign |
Het |
Obscn |
A |
G |
11: 58,890,846 (GRCm39) |
S7229P |
unknown |
Het |
Or1l4b |
A |
T |
2: 37,036,427 (GRCm39) |
I68F |
probably damaging |
Het |
Pfkp |
G |
A |
13: 6,650,708 (GRCm39) |
|
probably benign |
Het |
Pop1 |
T |
A |
15: 34,502,619 (GRCm39) |
I102K |
probably damaging |
Het |
Ppp1r21 |
A |
G |
17: 88,891,290 (GRCm39) |
M732V |
probably benign |
Het |
Rsc1a1 |
A |
G |
4: 141,412,408 (GRCm39) |
V168A |
probably benign |
Het |
Scd2 |
G |
A |
19: 44,289,685 (GRCm39) |
V227I |
probably benign |
Het |
Scn10a |
T |
A |
9: 119,495,125 (GRCm39) |
Y372F |
probably damaging |
Het |
Slc35c2 |
G |
T |
2: 165,124,055 (GRCm39) |
T94K |
probably damaging |
Het |
Slc41a2 |
A |
G |
10: 83,119,728 (GRCm39) |
Y345H |
probably benign |
Het |
Slc5a11 |
T |
C |
7: 122,864,854 (GRCm39) |
S387P |
probably damaging |
Het |
Smg7 |
T |
A |
1: 152,721,145 (GRCm39) |
N727I |
probably benign |
Het |
Tex2 |
T |
A |
11: 106,459,058 (GRCm39) |
|
probably benign |
Het |
Tmem79 |
A |
G |
3: 88,240,270 (GRCm39) |
L226P |
probably damaging |
Het |
Tnfrsf14 |
G |
T |
4: 155,008,927 (GRCm39) |
C165* |
probably null |
Het |
Trim21 |
A |
G |
7: 102,208,870 (GRCm39) |
V283A |
probably benign |
Het |
Vmn2r16 |
A |
T |
5: 109,487,948 (GRCm39) |
M274L |
probably benign |
Het |
|
Other mutations in Steap2 |
Allele | Source | Chr | Coord | Type | Predicted Effect | PPH Score |
IGL02052:Steap2
|
APN |
5 |
5,723,586 (GRCm39) |
missense |
probably damaging |
0.99 |
IGL02272:Steap2
|
APN |
5 |
5,727,612 (GRCm39) |
missense |
probably benign |
0.10 |
R0267:Steap2
|
UTSW |
5 |
5,723,561 (GRCm39) |
missense |
probably benign |
0.00 |
R1670:Steap2
|
UTSW |
5 |
5,727,393 (GRCm39) |
missense |
possibly damaging |
0.80 |
R2175:Steap2
|
UTSW |
5 |
5,723,501 (GRCm39) |
missense |
probably damaging |
1.00 |
R2188:Steap2
|
UTSW |
5 |
5,723,643 (GRCm39) |
nonsense |
probably null |
|
R2374:Steap2
|
UTSW |
5 |
5,725,845 (GRCm39) |
missense |
probably damaging |
0.99 |
R4902:Steap2
|
UTSW |
5 |
5,725,866 (GRCm39) |
missense |
possibly damaging |
0.91 |
R4941:Steap2
|
UTSW |
5 |
5,727,651 (GRCm39) |
missense |
probably damaging |
1.00 |
R5012:Steap2
|
UTSW |
5 |
5,727,784 (GRCm39) |
missense |
possibly damaging |
0.48 |
R5555:Steap2
|
UTSW |
5 |
5,727,544 (GRCm39) |
missense |
possibly damaging |
0.89 |
R5571:Steap2
|
UTSW |
5 |
5,725,912 (GRCm39) |
missense |
probably damaging |
1.00 |
R5666:Steap2
|
UTSW |
5 |
5,723,681 (GRCm39) |
missense |
probably benign |
0.00 |
R5670:Steap2
|
UTSW |
5 |
5,723,681 (GRCm39) |
missense |
probably benign |
0.00 |
R5677:Steap2
|
UTSW |
5 |
5,727,497 (GRCm39) |
nonsense |
probably null |
|
R6101:Steap2
|
UTSW |
5 |
5,725,891 (GRCm39) |
missense |
possibly damaging |
0.71 |
R6105:Steap2
|
UTSW |
5 |
5,725,891 (GRCm39) |
missense |
possibly damaging |
0.71 |
R6190:Steap2
|
UTSW |
5 |
5,725,881 (GRCm39) |
missense |
probably damaging |
1.00 |
R7172:Steap2
|
UTSW |
5 |
5,732,896 (GRCm39) |
missense |
possibly damaging |
0.52 |
R7576:Steap2
|
UTSW |
5 |
5,727,406 (GRCm39) |
missense |
probably benign |
0.01 |
R7706:Steap2
|
UTSW |
5 |
5,732,967 (GRCm39) |
missense |
possibly damaging |
0.95 |
R8747:Steap2
|
UTSW |
5 |
5,723,539 (GRCm39) |
missense |
probably benign |
0.36 |
R9020:Steap2
|
UTSW |
5 |
5,723,480 (GRCm39) |
missense |
probably benign |
0.00 |
R9040:Steap2
|
UTSW |
5 |
5,732,722 (GRCm39) |
missense |
probably benign |
|
R9113:Steap2
|
UTSW |
5 |
5,727,475 (GRCm39) |
missense |
probably damaging |
1.00 |
|
Posted On |
2015-04-16 |